Evidence map›Paper›PMID 38742376›Full record

Observational studyJournal of the American Geriatrics Society2024

Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE-AF study.

Deepti S Athreya, Jane S Saczynski, Jerry H Gurwitz, Kevin M Monahan, Benita A Bamgbade, Tenes J Paul, Felix Sogade, Darleen M Lessard, David D McManus, Robert H Helm

Abstract readObservational Study
In one paragraph

Observational study in Journal of the American Geriatrics Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Diversity, equity, and inclusion in arrhythmia care: a European Heart Rhythm Association survey.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Deepti S AthreyaCollege of Science, Northeastern University, Boston, Massachusetts, USA.
Jane S SaczynskiDepartment of Pharmacy and Health System Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Jerry H GurwitzMeyers Primary Care Institute and Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Kevin M MonahanEvans Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Benita A BamgbadeDepartment of Pharmacy and Health System Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0003-1645-5838
Tenes J PaulDivision of Cardiology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Felix SogadeDepartment of Medicine, Mercer University School of Medicine, Mercer, Georgia, USA.
Darleen M LessardDivision of Epidemiology of Chronic Diseases, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
David D McManusDivision of Cardiology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Robert H HelmEvans Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-4562-6950

Funding

Detecting bleeding events using EHRs for prediction in AfibR01HL137794 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MCMANUS, DAVID D., YU, HONG · 2018 to 2021
$3.3M
Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF)R01HL126911 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MCMANUS, DAVID D., SACZYNSKI, JANE STEELE · 2016 to 2019
$3.2M
Smartwatch Monitoring for Atrial Fibrillation After StrokeR01HL137734 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CHON, KI H, MCMANUS, DAVID D. · 2018 to 2021
$3.1M
FHS-NEXT - Framingham Novel EXam using TechnologyR01HL141434 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J., MCMANUS, DAVID D. · 2019 to 2022
$2.5M
Understanding Oral Anticoagulation Use and Success Among Patients with Psychiatric Multimorbidity in Atrial FibrillationK01HL155236 · NHLBI · NORTHEASTERN UNIVERSITY · PI BAMGBADE, BENITA A · 2021 to 2025
$808k
NHLBI NIH HHS 5R01HL126911-04NHLBI NIH HHS K01 HL155236NHLBI NIH HHS R01 HL126911NHLBI NIH HHS R01HL13660NHLBI NIH HHS R01 HL137734NHLBI NIH HHS R01HL137734NHLBI NIH HHS R01 HL137794NHLBI NIH HHS R01HL137794NHLBI NIH HHS R01 HL141434NHLBI NIH HHS R01HL141434
6 · The paper itself

Abstract

backgroundCognitive impairment is strongly associated with atrial fibrillation (AF). Rate and rhythm control are the two treatment strategies for AF and the effect of treatment strategy on risk of cognitive decline and frailty is not well established. We sought to determine how treatment strategy affects geriatric-centered outcomes.

methodsThe Systematic Assessment of Geriatric Elements-AF (SAGE-AF) was a prospective, observational, cohort study. Older adults with AF were prospectively enrolled between 2016 and 2018 and followed longitudinally for 2 years. In a non-randomized fashion, participants were grouped by rate or rhythm control treatment strategy based on clinical treatment at enrollment. Baseline characteristics were compared. Longitudinal binary mixed models were used to compare treatment strategy with respect to change in cognitive function and frailty status. Cognitive function and frailty status were assessed with the Montreal Cognitive Assessment Battery and Fried frailty phenotype tools.

results972 participants (mean age = 75, SD = 6.8; 49% female, 87% non-Hispanic white) completed baseline examination and 2-year follow-up. 408 (42%) were treated with rate control and 564 (58%) with rhythm control. The patient characteristics of the two groups were different at baseline. Participants in the rate control group were older, more likely to have persistent AF, prior stroke, be treated with warfarin and have baseline cognitive impairment. After adjusting for baseline differences, participants treated with rate control were 1.5 times more likely to be cognitively impaired over 2 years (adjusted OR: 1.47, 95% CI:1.12, 1.98) and had a greater decline in cognitive function (adjusted estimate: -0.59 (0.23), p < 0.01) in comparison to rhythm control. Frailty did not vary between the treatment strategies.

conclusionsAmong those who had 2-year follow-up in non-randomized observational cohort, the decision to rate control AF in older adults was associated with increased odds of decline in cognitive function but not frailty.

Indexed as

Atrial FibrillationCognitive DysfunctionAgedAged, 80 and overAnti-Arrhythmia AgentsAnticoagulantsFemaleFrailtyGeriatric AssessmentHumansLongitudinal StudiesMaleProspective StudiesAnti-Arrhythmia AgentsAnticoagulantsatrial fibrillationcognitive impairmentfrailtyolder adultsrate versus rhythm control

Identifiers

PMID38742376
PMCPMC11610796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.